SCHEMBL7003070

SCHEMBL7003070

CCn1c(=O)c2c(nc(C3CCCC3)n2Cc2ccccc2)n2nc(CN)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 7/20 0.48
KMT2A Q03164 1/20 0.48
ADORA3 P0DMS8 5/20 0.42
MAPK1 P28482 2/20 0.40
TP53 P04637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TSHR P16473 1/20 0.40
ADORA2A P29274 3/20 0.40
MAPT P10636 1/20 0.40
ADORA1 P30542 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADORA2B P29275 2/20 0.39
POLB P06746 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001362 0.91 KMT2A (0.48) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL6999063 0.91 KMT2A (0.48) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL6996654 0.89 KMT2A (0.46) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL6996208 0.89 PDE5A (0.47) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL7003426 0.88 KMT2A (0.46) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL7006028 0.88 KMT2A (0.45) PDE5AKMT2AADORA3MAPK1ADORA2A
SCHEMBL7003453 0.86 PDE5A (0.45) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL7005525 0.85 KMT2A (0.48) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL7668666 0.83 POLB (0.47) PDE5AKMT2AADORA3MAPK1TP53
SCHEMBL7666397 0.76 KMT2A (0.40) PDE5AKMT2AADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087973-B1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA (DE) 2003-01-08 EP disclosed
US-6492377-B1 Imidazotriazolopyrimidines with adenosine-antagonistic activity BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-12-10 US disclosed
EP-1087973-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY Boehringer Ingelheim Pharma KG (DE) 2001-04-04 EP disclosed
WO-2000012511-A1 IMIDAZOTRIAZOLOPYRIMIDINES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-03-09 WO disclosed
WO-1999065912-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-23 WO disclosed